SCD and squamous cell carcinoma: On the other hand, a metabolic basis of the antiproliferative effect triggered by SCD1 blockade has been reported in squamous cell carcinoma of the hypopharynx as the cell growth inhibitory effect produced by SCD1 depletion was found to be rescued by addition of BSA-conjugated oleic acid [26].